Constellium SE (CSTM) director John Ormerod discloses 32,873 shares

Rhea-AI Filing Summary

Constellium SE director John Ormerod has filed an initial statement of beneficial ownership. As of the event date of 01/01/2026, he reports owning 32,873 ordinary shares of Constellium SE, held with direct ownership. This filing records his starting equity position as an insider director of the company.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ormerod John

(Last) (First) (Middle)

300 EAST LOMBARD STREET

SUITE 1710

(Street)

BALTIMORE MD 21202

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
CONSTELLIUM SE [ CSTM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	32,873	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kristine Carpenter, Attorney-in-Fact for John Ormerod	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider position was reported for Constellium SE (CSTM)?

Director John Ormerod reported beneficial ownership of 32,873 ordinary shares of Constellium SE.

Is the Constellium SE (CSTM) insider ownership held directly or indirectly?

The 32,873 ordinary shares reported by John Ormerod are held with direct ownership.

What is the event date for this Constellium SE (CSTM) insider ownership report?

The date of the event requiring the statement is 01/01/2026.

What is John Ormerod’s relationship to Constellium SE (CSTM)?

John Ormerod is disclosed as a director of Constellium SE.

Does this Constellium SE (CSTM) filing show any derivative securities?

The table for derivative securities is included but shows no derivative holdings listed for John Ormerod in the provided content.

Who signed the Constellium SE (CSTM) insider ownership report?

The report was signed by Kristine Carpenter as Attorney-in-Fact for John Ormerod on 01/02/2026.